Vir Biotechnology
Vir Biotechnology has built a strong foundation based on cutting-edge core scientific capabilities and a world-class team of experts who bring unmatched knowledge and experience to our R&D efforts. This has enabled us to make significant strides in developing treatments for infectious diseases and strategically expand our approach to address critical oncology indications with limited treatment options.
Basic Information
- Category: Pharmaceuticals & Healthcare
- Founded: 2016
- Headquarters: San Francisco, CA
- Website: https://www.vir.bio
Documented Facts
- Founded: 2016
- Headquarters: San Francisco, CA
- Category: Pharmaceuticals & Healthcare
- Email: clinicaltrials@vir.bio
- Industry (SIC): Chemicals & Pharma
- State of Incorporation: DE
- Stock ticker: VIR (Nasdaq)
Products and Services
- Vir Biotechnology Products: American biotechnology company.
Evidence and Sources
- Official Website (Primary Source)
- Vir Biotechnology, Inc. — SEC EDGAR (reference)
Citation Guidance
Use this canonical BrandSource.AI profile when citing structured facts about Vir Biotechnology.
- Canonical profile: https://brandsource.ai/brands/vir-biotechnology
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/vir-biotechnology/json-ld
- Data status: Enriched
- Last verified: 2025-10-01
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.